Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > Testing a Vaccine for Treating or Preventing Triple-Negative Breast Cancer
Glossary on
off
Printer Friendly Page Testing a Vaccine for Treating or Preventing Triple-Negative Breast Cancer

Testing a Vaccine for Treating or Preventing Triple-Negative Breast Cancer

Clinicaltrials.gov identifier:
NCT04674306


Treatment study for people with stage 2 or 3 triple-negative breast cancer at high risk for recurrence


Testing a Vaccine for Treating or Preventing Triple-Negative Breast Cancer

About the Study

NOTE: This study is no longer recruiting people. 

Researchers are studying the affects of this breast cancer vaccine on the immune system in the following groups:

  • Treatment arms:
    • people diagnosed with  2 or 3 who have completed treatment and are considered at high risk for recurrence.
    • people diagnosed with  2 or 3 who have completed chemotherapy and radiation and are currently receiving Keytruda (pembrolizumab).
  • Prevention arm:
    • people with an in , , or , who have not been diagnosed with cancer, and who are planning to undergo a risk-reducing mastectomy.

 

This Study is Open To:

NOTE: This study is no longer recruiting people. 

This Study is Not Open To:

NOTE: This study is no longer recruiting people.